A comprehensive view of Obesity. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Food & Beverage Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Survey finds 54% of dog owners and 56% of cat owners rank reducing calories as most effective to help pets lose weight; 11% of dog owners, 23% of cat owners find therapeutic, prescription diets most effective: Assn. for the Prevention of Pet Obesity

Eli Lilly listed a new US clinical trial to study once-daily oral orforglipron LY3502970 in adults with obesity or overweight with weight-related comorbidities

Bank of America raises Eli Lilly's target to US$500, estimates demand for its obesity drugĀ Tirzepatide to increase by 40% over next seven years and become US$20B drug by 2030; Eli Lilly expects FDA approval for the drug by end-2023

Peer-reviewed study finds Pfizer's danuglipron oral weight loss drug proves as effective as Novo Nordisk's Ozempic injection in clinical trial; Pfizer drug offers a potentially more convenient treatment option: JAMA Network

Moody's warns side-effect risks, misuse, payer issues could dampen market for new weight loss drugs; US health care costs tied to obesity reached US$173B in 2019 dollars, creating huge market for cost-effective weight loss drugs

Ask us about our Food & Beverage market view

Trending Chart

Interactive chart with headline count